These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26543365)

  • 21. Chloroquine Sensitizes Esophageal Carcinoma EC109 Cells to Paclitaxel by Inhibiting Autophagy.
    Yuan Z; Cai J; Du Q; Ma Q; Xu L; Cai Y; Zhong X; Guo X
    Crit Rev Eukaryot Gene Expr; 2023; 33(6):43-53. PubMed ID: 37522544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.
    Ravar F; Saadat E; Kelishadi PD; Dorkoosh FA
    J Liposome Res; 2016 Sep; 26(3):175-87. PubMed ID: 26266828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
    Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.
    Hong C; Wang D; Liang J; Guo Y; Zhu Y; Xia J; Qin J; Zhan H; Wang J
    Theranostics; 2019; 9(15):4437-4449. PubMed ID: 31285771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
    Li Y; Chen Z; Cui Y; Zhai G; Li L
    Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
    Koshkina NV; Golunski E; Roberts LE; Gilbert BE; Knight V
    J Aerosol Med; 2004; 17(1):7-14. PubMed ID: 15120008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
    Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
    Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
    Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
    Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
    Lv X; Liu F; Shang Y; Chen SZ
    Oncol Rep; 2015 Sep; 34(3):1289-300. PubMed ID: 26136140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
    Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
    J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
    Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
    Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
    Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
    Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
    Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes.
    Peres-Filho MJ; Dos Santos AP; Nascimento TL; de Ávila RI; Ferreira FS; Valadares MC; Lima EM
    AAPS PharmSciTech; 2018 Jan; 19(1):201-212. PubMed ID: 28681330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.